TLIS: Talis Biomedical Corporation Stock

SIC 3826 – Laboratory Analytical Instruments

Valuation
Market Cap ($M) 7.98
Enterprise Value ($M) -51.88
Book Value ($M) 48.63
Book Value / Share 26.68
Price / Book 0.16
NCAV ($M) 39.53
NCAV / Share 21.69
Price / NCAV 0.20

Profitability (mra)
Return on Invested Capital (ROIC) -0.76
Return on Assets (ROA) -0.54
Return on Equity (ROE) -0.74

Liquidity (mrq)
Quick Ratio 7.76
Current Ratio 7.76

Balance Sheet (mrq) ($M)
Current Assets 63.60
Assets 72.70
Liabilities 24.07
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
10-10 13D/A Baker Bros. Advisors Lp 65.60 -93.33
08-14 13G BML Investment Partners, L.P. 7.40
02-14 13G/A Greenlight Capital Inc 8.20

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)

Similar Companies
SSMXF – Sysmex Corporation THMO – ThermoGenesis Holdings, Inc.
TKOI – Telkonet, Inc. TMRNF – Tamron Co.,Ltd.
TRCC – Traccom Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.